Table of Contents Table of Contents
Previous Page  12 / 236 Next Page
Information
Show Menu
Previous Page 12 / 236 Next Page
Page Background

Orlandi RR, Smith TL, Marple BF, et al. Update on evidence-based reviews with

recommendations in adult chronic rhinosinusitis.

Int Forum Allergy Rhinol

. 2014; 4

Suppl 1: S1-S15. EBM level NA...............................................................................32-46

Summary

: Orlandi et al present expert panel guidelines based on a systematic literature review.

This review synthesizes the findings of eight evidence-based reviews with recommendations

regarding chronic rhinosinusitis published in the

International Forum of Allergy and Rhinology

between 2011 and 2014.

c.

Subtypes of CRS

Han JK. Subclassification of chronic rhinosinusitis.

Laryngoscope

. 2013; 123 Suppl

2:S15-S27. EBM level 2b...........................................................................................47-59

Summary

: This article presents a working classification of the common clinical subtypes of

chronic rhinosinusitis (CRS). The author presents a clinical and laboratory work-up to subtype

CRS.

2.

Pathophysiology

a.

Pathophysiology of CRS

i.

Role of innate and adaptive immunity

Adappa ND, Zhang Z, Palmer JN, et al. The bitter taste receptor T2R38 is an

independent risk factor for chronic rhinosinusitis requiring sinus surgery.

Int

Forum Allergy Rhinol

. 2014; 4(1):3-7. EBM level NA..................................60-64

Summary

: Adappa et al studied tissue of chronic rhinosinusitis (CRS) patients undergoing

primary functional endoscopic sinus surgery. The tissue was studied for genotype

TAS2R38

. The

TAS2R38

genotype was found to be an independent risk factor for CRS

patients who failed medical therapy and required surgical intervention.

Hox V, Maes T, Huvenne W, et al. A chest physician's guide to mechanisms of

sinonasal disease.

Thorax

. 2015; 70(4):353-358. EBM level 4.....................65-70

Summary

: This review focuses on both endogenous predisposing factors and exogenous

triggers that may contribute to chronic upper airway disease and can also impact lower

airway disease.

Oakley GM, Curtin K, Orb Q, et al. Familial risk of chronic rhinosinusitis with

and without nasal polyposis: genetics or environment.

Int Forum Allergy Rhinol

.

2015; 5(4):276-282. EBM level 3....................................................................71-77

Summary

: This study used an extensive genealogical database from the state of Utah and

linked medical records to study the risk of chronic rhinosinusitis with nasal polyps

(CRSwNP) and without polyps (CRSsNP) in relatives and spouses of adult probands

(1638 CRSwNP and 24,200 CRSsNP patients). These were compared to random

population controls matched 5:1 on gender and birth year.

ii.

Microbiome

b.

Pathophysiology of tumors

Tajudeen BA, Arshi A, Suh JD, et al. Importance of tumor grade in

esthesioneuroblastoma survival: a population-based analysis.

JAMA Otolaryngol Head

Neck Surg

. 2014; 140(12):1124-1129. EBM level NA.............................................78-83

Summary

: This article is a population database review presenting tumor-related outcomes and the

impact of tumor grade/adjuvant radiation therapy on outcomes.